Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioCryst Pharmaceuticals Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
BCRX
Nasdaq
2836
https://www.biocryst.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioCryst Pharmaceuticals Inc
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
- May 15th, 2024 3:00 pm
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
- May 15th, 2024 3:00 pm
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
- May 15th, 2024 3:00 pm
Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)
- May 15th, 2024 3:00 pm
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
- May 14th, 2024 11:00 am
ORLADEYO® (berotralstat) Approved in Mexico
- May 13th, 2024 11:00 am
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
- May 9th, 2024 11:00 am
Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results
- May 9th, 2024 10:47 am
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
- May 7th, 2024 2:50 pm
BioCryst to Present at Upcoming Investor Conferences
- May 7th, 2024 11:00 am
BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
- May 7th, 2024 10:23 am
BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
- May 7th, 2024 7:01 am
Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call
- May 7th, 2024 5:13 am
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
- May 6th, 2024 10:47 pm
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
- May 6th, 2024 8:59 pm
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
- May 6th, 2024 5:00 pm
BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts
- May 6th, 2024 12:32 pm
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
- May 6th, 2024 12:10 pm
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
- May 6th, 2024 11:00 am
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- May 3rd, 2024 11:00 am
Scroll